Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 1 de 1
Filter
Add more filters










Database
Language
Publication year range
1.
J Clin Sleep Med ; 5(1): 68-9, 2009 Feb 15.
Article in English | MEDLINE | ID: mdl-19317385

ABSTRACT

We report a case of severe restless legs syndrome (RLS) that occurred as a side effect of olanzapine therapy. It was refractory to treatment with 2 mg of clonazepam and 3 mg ropinirole. There was partial relief with propoxyphene, however, it was stopped because of side effects. The symptoms disappeared once olanzapine was switched to another antipsychotic medication. Only two prior published reports associate olanzapine usage with development of RLS. In one report, low-dose benzodiazepines and ropinirole were associated with resolution of RLS symptoms stating dopamine depletion as the likely etiology. In our patient, however, RLS due to olanzapine was refractory to the trial of both high-dose benzodiazepine and ropinirole. This suggests that RLS occurring as a side effect of olanzapine therapy may have additional causative mechanisms beyond simple dopamine depletion as postulated before. High-dose narcotics, if tolerated, may be an alternative in such refractory cases.


Subject(s)
Antipsychotic Agents/adverse effects , Benzodiazepines/adverse effects , Bipolar Disorder/drug therapy , Restless Legs Syndrome/chemically induced , Anticonvulsants/therapeutic use , Antipsychotic Agents/therapeutic use , Aripiprazole , Benzodiazepines/therapeutic use , Bipolar Disorder/diagnosis , Drug Therapy, Combination , Female , Humans , Middle Aged , Olanzapine , Piperazines/therapeutic use , Quinolones/therapeutic use , Restless Legs Syndrome/diagnosis , Valproic Acid/therapeutic use
SELECTION OF CITATIONS
SEARCH DETAIL
...